(S)-(E)-Luliconazole isomer is a stereoisomer of the active pharmaceutical ingredient (API) luliconazole. Luliconazole itself is a broad-spectrum imidazole antifungal agent used topically to treat dermatophyte infections such as athlete's foot, jock itch, and ringworm. Its mechanism of action involves the inhibition of lanosterol 14α-demethylase, a key enzyme in ergosterol biosynthesis, thereby disrupting fungal cell membrane integrity. This specific isomer, (S)-(E)-Luliconazole, is not the therapeutically active form. The commercial drug product utilizes the (R)-(E)-enantiomer. Consequently, the (S)-(E)-isomer is primarily relevant in pharmaceutical development and quality control as a chiral impurity or a reference standard. It is used to monitor stereochemical purity during the synthesis of luliconazole API and to ensure the final drug product meets stringent regulatory specifications regarding enantiomeric excess.